MedPath

The effect of oestrogen replacement therapy on urinary tract dysfunction and urogenital collagen structure in postmenopausal women with stress incontinence

Completed
Conditions
rological and genital diseases: Incontinence
Urological and Genital Diseases
Incontinence
Registration Number
ISRCTN06344732
Lead Sponsor
HS R&D Regional Programme Register - Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
67
Inclusion Criteria

Post-menopausal women with genuine stress incontinence, not taking hormone replacement therapy

Exclusion Criteria

Not provided at time of registration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment prior to treatment and upon study completion with the SF-36 health status questionnaire, the Bristol Female Lower Urinary Tract Symptoms questionnaire, a one week urinary diary, one hour perineal pad test, cystometry and urethral profilometry.
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath